FAIL (the browser should render some flash content, not this).

From shopping for a wheelchair to "fast and effective relief". Sufferer relieved from acute diabetic nerve pain


A common complication of diabetes is damage to the nerves that allow patients to feel sensations such as numbness and debilitating pain. This condition is called diabetic nerve pain. While less than 3 percent of the general population is affected, eventually 60 percent of diabetics will develop some degree of nerve damage in their feet or hands.

According to the American Diabetes Association, more than 20.8 million Americans have diabetes. By the end of the decade, this number is expected to rise even more. Diabetic nerve pain occurs when high blood sugar levels damage nerves, producing symptoms in approximately 40 percent of diabetics.

Mostly it affects the hands and feet, with symptoms of numbness, ranging from mild to severe, and pins and needles pain. Limbs feel alternately burning hot and icy cold, accompanied by sharp or dull pain and muscle fatigue.

Treating diabetes may halt progression and improve symptoms of the neuropathy, but recovery is slow. The painful sensations of diabetic nerve pain may become so severe it can lead to depression in some patients.

This chronic painful condition is often puzzling and frustrating for patients and physicians, as it is difficult to diagnose and seems to respond poorly to standard pain therapies. Countless American diabetics have suffered from peripheral nerve pain for years with no relief in sight -- until now.

A topical pain reliever Neuragen, developed by Origin BioMed Inc., a Halifax-based manufacturer of over-the-counter topical drug products, is finally providing relief for sufferers of nerve pain.

Neuragen is a topical preparation scientifically studied since the early 1990s. Recent clinical studies at Louisiana State University have confirmed the efficacy of Neuragen in the treatment of post-shingles neuralgia and other types of nerve pain. It was found to provide substantial relief in 85 percent of patients.

Neuragen is now available nationally through select CVS/pharmacy stores and leading pharmacies across the country. The increased availability of this effective treatment option is welcome news for patients.

Diabetic nerve pain sufferer, Ron Morrison developed so much discomfort from his condition in his legs and feet that he was "seriously shopping for a wheelchair because it was becoming too difficult to stand and walk," he admitted. "I was introduced to a wonderful new product at my local pharmacy, Neuragen that provided relief from this burning sensation in my feet and have been using this product ever since. It has returned quality back to my life." More information on Neuragen and neuropathy is available at www.originbiomed.com and www.diabetes.org.